RxDoctor Payments Data

Tyler Stanfield, PA

Physician Assistant · Selmer, TNNPI 1780243915

Payments from drug & device makers

$1,140in general payments, 2019–2025

Across 63 payments — averaging $18.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$372
  • AstraZeneca$251
  • Novo Nordisk$196
  • Axsome Therapeutics, Inc.$50
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$48
  • Pfizer$46
  • plus $177 from 8 others

What the payments were for

  • Food & beverage$1,140100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,140 in reported general payments places this provider in the 70th percentile of 2,404 physician assistant providers in Tennessee.

See all physician assistant providers in Tennessee

Medicare billing

Part B allowed, 2024
$1,195
Medicare patients
34
Services billed
49

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
HetliozTasimelteon12$268,565
OzempicSemaglutide73$74,586
Trelegy ElliptaFluticasone/Umeclidin/Vilanter63$40,075
FarxigaDapagliflozin Propanediol44$38,996
EliquisApixaban60$37,907
LinzessLinaclotide37$32,415
VraylarCariprazine Hcl20$27,882
JardianceEmpagliflozin17$22,272
TrulicityDulaglutide21$20,029
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog15$8,142
Levemir FlexpenInsulin Detemir23$6,572
Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl62$5,667
Albuterol Sulfate HfaAlbuterol Sulfate114$3,106
Lantus SolostarInsulin Glargine,hum.Rec.Anlog21$2,493
Novolog FlexpenInsulin Aspart16$2,294

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Novolog$196$75,57686 claims
AbbVieLinzess, Vraylar$372$60,29757 claims
AstraZenecaFarxiga$251$38,99644 claims
PfizerEliquis$46$37,90760 claims
Lilly USA, LLCTrulicity$16$20,02921 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 2,404 physician assistant providers in Tennessee.

Other physician assistant in Selmer

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →